On the public citation graph
Biological Networks and Drug Discovery—Where Do We Stand?
0 signed · 126 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9781118274408.ch8openalex-snapshot
Systematic Phenotypic Screening for Novel Synergistic Combinations: A New Paradigm for Repositioning Existing Drugs
inferredcites →https://doi.org/10.1007/s12170-012-0280-yopenalex-snapshot
Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases
inferredcites →https://doi.org/10.1016/b978-0-12-375003-7.00002-9openalex-snapshot
Genes and Pathways Contributing to Obesity
inferredcites →https://doi.org/10.1016/j.ajhg.2008.02.013openalex-snapshot
Walking the Interactome for Prioritization of Candidate Disease Genes
inferredcites →https://doi.org/10.1016/j.ajhg.2011.11.029openalex-snapshot
Five Years of GWAS Discovery
inferredcites →https://doi.org/10.1016/j.bcp.2013.08.006openalex-snapshot
Animal models of human disease: Challenges in enabling translation
inferredcites →https://doi.org/10.1016/j.bcp.2013.09.011openalex-snapshot
The fall and rise of pharmacology – (Re-)defining the discipline?
inferredcites →https://doi.org/10.1016/j.bmcl.2012.12.031openalex-snapshot
Understanding drugs and diseases by systems biology?
inferredcites →https://doi.org/10.1016/j.cbpa.2012.12.022openalex-snapshot
Target deconvolution techniques in modern phenotypic profiling
inferredcites →https://doi.org/10.1016/j.cell.2012.03.031openalex-snapshot
Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
inferredcites →https://doi.org/10.1016/j.ddtec.2006.12.008openalex-snapshot
In silico target fishing: Predicting biological targets from chemical structure
inferredcites →https://doi.org/10.1016/j.drudis.2006.11.008openalex-snapshot
Multi-target therapeutics: when the whole is greater than the sum of the parts
inferredcites →https://doi.org/10.1016/j.drudis.2012.10.010openalex-snapshot
Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift
inferredcites →https://doi.org/10.1016/j.drudis.2013.01.008openalex-snapshot
Shifting from the single to the multitarget paradigm in drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2013.02.006openalex-snapshot
Designed multiple ligands in metabolic disease research: from concept to platform
inferredcites →https://doi.org/10.1016/j.drudis.2013.03.002openalex-snapshot
Compound promiscuity: what can we learn from current data?
inferredcites →https://doi.org/10.1016/j.drudis.2013.07.001openalex-snapshot
Phenotypic screens as a renewed approach for drug discovery
inferredcites →https://doi.org/10.1016/j.drudis.2014.03.004openalex-snapshot
Towards a sustainable system of drug development
inferredcites →https://doi.org/10.1016/j.gde.2013.10.003openalex-snapshot
Genotype to phenotype via network analysis
inferredcites →https://doi.org/10.1016/j.jprot.2011.05.011openalex-snapshot
From in silico target prediction to multi-target drug design: Current databases, methods and applications
inferredcites →https://doi.org/10.1016/j.pharmthera.2013.01.016openalex-snapshot
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
inferredcites →https://doi.org/10.1016/j.sbi.2011.01.004openalex-snapshot
Structure-based systems biology for analyzing off-target binding
inferredcites →https://doi.org/10.1016/j.tibtech.2010.02.005openalex-snapshot
High content screening: seeing is believing
inferredcites →https://doi.org/10.1016/j.tips.2005.02.007openalex-snapshot
The efficiency of multi-target drugs: the network approach might help drug design
inferredcites →https://doi.org/10.1016/s0163-7258(00)00039-5openalex-snapshot
Traditional Chinese medicine an approach to scientific proof and clinical validation
inferredcites →https://doi.org/10.1016/s1359-6446(04)03163-0openalex-snapshot
From magic bullets to designed multiple ligands
inferredcites →https://doi.org/10.1021/cn500051hopenalex-snapshot
Back to the Future with Phenotypic Screening
inferredcites →https://doi.org/10.1021/jm058225dopenalex-snapshot
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
inferredcites →https://doi.org/10.1021/jm201649sopenalex-snapshot
Modern Phenotypic Drug Discovery Is a Viable, Neoclassic Pharma Strategy
inferredcites →https://doi.org/10.1021/jm7009364openalex-snapshot
Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
inferredcites →https://doi.org/10.1021/jm901132vopenalex-snapshot
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
inferredcites →https://doi.org/10.1038/35019019openalex-snapshot
Error and attack tolerance of complex networks
inferredcites →https://doi.org/10.1038/msb4100179openalex-snapshot
Towards a theory of biological robustness
inferredcites →https://doi.org/10.1038/nature01626openalex-snapshot
A vision for the future of genomics research
inferredcites →https://doi.org/10.1038/nature03001openalex-snapshot
Finishing the euchromatic sequence of the human genome
inferredcites →https://doi.org/10.1038/nature09792openalex-snapshot
Initial impact of the sequencing of the human genome
inferredcites →https://doi.org/10.1038/nature11691openalex-snapshot
Automated design of ligands to polypharmacological profiles
inferredcites →https://doi.org/10.1038/nchembio.118openalex-snapshot
Network pharmacology: the next paradigm in drug discovery
inferredcites →https://doi.org/10.1038/nchembio.1206openalex-snapshot
The why and how of phenotypic small-molecule screens
inferredcites →https://doi.org/10.1038/nchembio.2007.53openalex-snapshot
Integrating high-content screening and ligand-target prediction to identify mechanism of action
inferredcites →https://doi.org/10.1038/nchembio.307openalex-snapshot
Rapid behavior-based identification of neuroactive small molecules in the zebrafish
inferredcites →https://doi.org/10.1038/nchembio817openalex-snapshot
Systems biology and combination therapy in the quest for clinical efficacy
inferredcites →https://doi.org/10.1038/nmeth.1599openalex-snapshot
High-content screening: getting more from less
inferredcites →https://doi.org/10.1038/nrd1346openalex-snapshot
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
inferredcites →https://doi.org/10.1038/nrd1470openalex-snapshot
Can the pharmaceutical industry reduce attrition rates?
inferredcites →https://doi.org/10.1038/nrd1609openalex-snapshot
Multicomponent therapeutics for networked systems
inferredcites →https://doi.org/10.1038/nrd2381openalex-snapshot
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
inferredcites →https://doi.org/10.1038/nrd2410openalex-snapshot
Target deconvolution strategies in drug discovery
inferredcites →https://doi.org/10.1038/nrd2519openalex-snapshot
Genome-wide association studies: progress and potential for drug discovery and development
inferredcites →https://doi.org/10.1038/nrd2683openalex-snapshot
Mechanisms of drug combinations: interaction and network perspectives
inferredcites →https://doi.org/10.1038/nrd2876openalex-snapshot
Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds
inferredcites →https://doi.org/10.1038/nrd3375openalex-snapshot
Phase III and submission failures: 2007–2010
inferredcites →https://doi.org/10.1038/nrd3681openalex-snapshot
Diagnosing the decline in pharmaceutical R&D efficiency
inferredcites →https://doi.org/10.1038/nrd3937openalex-snapshot
Targeting pathological B cell receptor signalling in lymphoid malignancies
inferredcites →https://doi.org/10.1038/nrd3981openalex-snapshot
Priorities for improving drug research, development and regulation
inferredcites →https://doi.org/10.1038/nrd4164openalex-snapshot
Does size matter in R&D productivity? If not, what does?
inferredcites →https://doi.org/10.1038/nrd4309openalex-snapshot
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
inferredcites →https://doi.org/10.1038/nrd4320openalex-snapshot
R&D productivity: on the comeback trail
inferredcites →https://doi.org/10.1038/nrg1272openalex-snapshot
Network biology: understanding the cell's functional organization
inferredcites →https://doi.org/10.1038/nrg2918openalex-snapshot
Network medicine: a network-based approach to human disease
inferredcites →https://doi.org/10.1038/nrg3433openalex-snapshot
Computational solutions for omics data
inferredcites →https://doi.org/10.1049/iet-syb.2010.0052openalex-snapshot
Network-based analysis of complex diseases
inferredcites →https://doi.org/10.1056/nejmp1101548openalex-snapshot
Development of Novel Combination Therapies
inferredcites →https://doi.org/10.1073/pnas.1204524109openalex-snapshot
Identifying mechanism-of-action targets for drugs and probes
inferredcites →https://doi.org/10.1073/pnas.1311846111openalex-snapshot
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells
inferredcites →https://doi.org/10.1073/pnas.1403080111openalex-snapshot
Exploiting polypharmacology for drug target deconvolution
inferredcites →https://doi.org/10.1089/cmb.2006.13.810openalex-snapshot
How Scale-Free Are Biological Networks
inferredcites →https://doi.org/10.1093/bib/bbl040openalex-snapshot
Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments
inferredcites →https://doi.org/10.1093/nar/gks1094openalex-snapshot
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
inferredcites →https://doi.org/10.1097/fjc.0b013e318247f642openalex-snapshot
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
inferredcites →https://doi.org/10.1101/gr.082214.108openalex-snapshot
Exploring the human genome with functional maps
inferredcites →https://doi.org/10.1103/physreve.71.051909openalex-snapshot
Multiple weak hits confuse complex systems: A transcriptional regulatory network as an example
inferredcites →https://doi.org/10.1111/febs.12057openalex-snapshot
Trade‐off of dynamic fragility but not of robustness in metabolic pathways in silico
inferredcites →https://doi.org/10.1124/jpet.110.171751openalex-snapshot
Productivity Shortfalls in Drug Discovery: Contributions from the Preclinical Sciences?
inferredcites →https://doi.org/10.1126/science.1180823openalex-snapshot
The Genetic Landscape of a Cell
inferredcites →https://doi.org/10.1126/science.1183090openalex-snapshot
Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation
inferredcites →https://doi.org/10.1126/scisignal.2000352openalex-snapshot
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis
inferredcites →https://doi.org/10.1126/scisignal.2003350openalex-snapshot
Cross-Species Protein Interactome Mapping Reveals Species-Specific Wiring of Stress Response Pathways
inferredcites →https://doi.org/10.1126/scisignal.2003363openalex-snapshot
Attractor Landscape Analysis Reveals Feedback Loops in the p53 Network That Control the Cellular Response to DNA Damage
inferredcites →https://doi.org/10.1146/annurev-pharmtox-010611-134630openalex-snapshot
Novel Computational Approaches to Polypharmacology as a Means to Define Responses to Individual Drugs
inferredcites →https://doi.org/10.1146/annurev.genom.2.1.343openalex-snapshot
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
inferredcites →https://doi.org/10.1158/1535-7163.mct-10-0642openalex-snapshot
Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
inferredcites →https://doi.org/10.1158/2159-8290.cd-12-0408openalex-snapshot
Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
inferredcites →https://doi.org/10.1186/1471-2105-14-361openalex-snapshot
Detection of attractors of large Boolean networks via exhaustive enumeration of appropriate subspaces of the state space
inferredcites →https://doi.org/10.1186/1752-0509-8-53openalex-snapshot
Stabilization of perturbed Boolean network attractors through compensatory interactions
inferredcites →https://doi.org/10.1186/gb-2009-10-9-r91openalex-snapshot
Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.8051openalex-snapshot
A randomized phase 2 trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with erlotinib in EGFR wild-type NSCLC patients.
inferredcites →https://doi.org/10.1242/jcs.02714openalex-snapshot
Scale-free networks in cell biology
inferredcites →https://doi.org/10.1371/journal.pcbi.1000140openalex-snapshot
Why Do Hubs in the Yeast Protein Interaction Network Tend To Be Essential: Reexamining the Connection between the Network Topology and Essentiality
inferredcites →https://doi.org/10.1371/journal.pcbi.1000387openalex-snapshot
Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors
inferredcites →https://doi.org/10.1371/journal.pcbi.1000550openalex-snapshot
Structure of Protein Interaction Networks and Their Implications on Drug Design
inferredcites →https://doi.org/10.1371/journal.pcbi.1000616openalex-snapshot
Meta-analysis of Inter-species Liver Co-expression Networks Elucidates Traits Associated with Common Human Diseases
inferredcites →https://doi.org/10.1371/journal.pcbi.1001099openalex-snapshot
Training Signaling Pathway Maps to Biochemical Data with Constrained Fuzzy Logic: Quantitative Analysis of Liver Cell Responses to Inflammatory Stimuli
inferredcites →https://doi.org/10.1371/journal.pcbi.1002129openalex-snapshot
A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1371/journal.pcbi.1003226openalex-snapshot
Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
inferredcites →https://doi.org/10.1371/journal.pcbi.1003290openalex-snapshot
Perturbation Biology: Inferring Signaling Networks in Cellular Systems
inferredcites →https://doi.org/10.1371/journal.pgen.0020088openalex-snapshot
Why Do Hubs Tend to Be Essential in Protein Networks?
inferredcites →https://doi.org/10.1371/journal.pone.0000988openalex-snapshot
An Improved, Bias-Reduced Probabilistic Functional Gene Network of Baker's Yeast, Saccharomyces cerevisiae
inferredcites →https://doi.org/10.1371/journal.pone.0004346openalex-snapshot
A Pathway-Based View of Human Diseases and Disease Relationships
inferredcites →https://doi.org/10.1371/journal.pone.0052581openalex-snapshot
A Conserved Mammalian Protein Interaction Network
inferredcites →https://doi.org/10.1371/journal.pone.0068598openalex-snapshot
Searching for Synergies: Matrix Algebraic Approaches for Efficient Pair Screening
inferredcites →https://doi.org/10.1371/journal.pone.0074335openalex-snapshot
Lessons Learned from Quantitative Dynamical Modeling in Systems Biology
inferredcites →https://doi.org/10.1371/journal.pone.0083940openalex-snapshot
Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
inferredcites →https://doi.org/10.1586/ecp.12.74openalex-snapshot
Polypharmacology: drug discovery for the future
inferredcites →https://doi.org/10.2202/1544-6115.1128openalex-snapshot
A General Framework for Weighted Gene Co-Expression Network Analysis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/ddr.21221openalex-snapshot
From Transcriptomics to Biological Networks
inferred← citeshttps://doi.org/10.1002/ddr.21337openalex-snapshot
Improving Current Treatments for Schizophrenia
inferred← citeshttps://doi.org/10.1007/s00216-016-0043-6openalex-snapshot
Active fragments-guided drug discovery and design of selective tropane alkaloids using ultra-high performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry coupled with virtual calculation and biological evaluation
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12298-xopenalex-snapshot
Structural Chemogenomics Databases to Navigate Protein–Ligand Interaction Space
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.12.001openalex-snapshot
Network-based technologies for early drug discovery
inferred← citeshttps://doi.org/10.1016/j.molmed.2014.10.002openalex-snapshot
A network approach to clinical intervention in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1101/044289openalex-snapshot
Structural and Functional View of Polypharmacology
inferred← citeshttps://doi.org/10.1103/physreve.94.062316openalex-snapshot
Compensatory interactions to stabilize multiple steady states or mitigate the effects of multiple deregulations in biological networks
inferred← citeshttps://doi.org/10.1155/2015/540297openalex-snapshot
A Glimpse to Background and Characteristics of Major Molecular Biological Networks
inferred← citeshttps://doi.org/10.11606/d.76.2017.tde-15092017-084415openalex-snapshot
Estudos computacionais da enzima N-miristoiltransferase de Plasmodium falciparum e seus inibidores como candidatos a agentes antimaláricos
inferred← citeshttps://doi.org/10.1371/journal.pone.0123292openalex-snapshot
Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
inferred← citeshttps://doi.org/10.3390/sym16040462openalex-snapshot
Exploring the Molecular Terrain: A Survey of Analytical Methods for Biological Network Analysis
inferred← citeshttps://doi.org/10.4155/fmc-2018-0287openalex-snapshot
Translating Unusual Computational Methods to Drug Discovery: Taking Advantage of Work in Other Fields
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.